MGI Tech Co., Ltd. engages in the research, development, production, and sale of DNA sequencing instruments, reagents, and related products for precision medicine, agriculture, healthcare, and other relevant industries in China and internationally. Its products include sequencers, such as genetic sequencers, sequencing reagents, library prep kits multiplex immunofluorescence reagent staining sets, and bioinformatics analysis; lab automation products comprising sample pretreatment products, sample preparation platforms, and integrated testing platforms; novel products, including STOmics, cell omics, ultrasound, BIT, and sample storage products, as well as microneedling products. The company was founded in 2016 and is headquartered in Shenzhen, China.
Metrics to compare | 688114 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship688114PeersSector | |
---|---|---|---|---|
P/E Ratio | −56.5x | 18.9x | −0.5x | |
PEG Ratio | −2.92 | 0.34 | 0.00 | |
Price/Book | 3.9x | 2.8x | 2.6x | |
Price / LTM Sales | 10.3x | 6.5x | 3.3x | |
Upside (Analyst Target) | 24.0% | 4.5% | 43.4% | |
Fair Value Upside | Unlock | −3.8% | 7.1% | Unlock |